258 related articles for article (PubMed ID: 33215769)
21. Costs and effects of on-demand treatment of hereditary angioedema in Italy: a prospective cohort study of 167 patients.
Federici C; Perego F; Borsoi L; Crosta V; Zanichelli A; Gidaro A; Tarricone R; Cicardi M
BMJ Open; 2018 Jul; 8(7):e022291. PubMed ID: 30061443
[TBL] [Abstract][Full Text] [Related]
22. Clinical Characteristics and Safety of Plasma-Derived C1-Inhibitor Therapy in Children and Adolescents with Hereditary Angioedema-A Long-Term Survey.
Farkas H; Kőhalmi KV; Visy B; Veszeli N; Varga L
J Allergy Clin Immunol Pract; 2020; 8(7):2379-2383. PubMed ID: 32198128
[TBL] [Abstract][Full Text] [Related]
23. Long term follow-up of complement parameters to improve the management of acquired angioedema due to C1-inhibitor deficiency.
Polai Z; Balla Z; Varga L; Benedek S; Farkas H
Heliyon; 2022 Nov; 8(11):e11292. PubMed ID: 36387475
[TBL] [Abstract][Full Text] [Related]
24. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
Zeerleder S; Levi M
Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
[TBL] [Abstract][Full Text] [Related]
25. Longitudinal experience with treatment of acquired angioedema using tranexamic acid.
Kesh S; Singh U; Bernstein JA
Allergy Asthma Proc; 2022 Sep; 43(5):413-418. PubMed ID: 36065111
[No Abstract] [Full Text] [Related]
26. A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum.
Kőhalmi KV; Veszeli N; Cervenak L; Varga L; Farkas H
Immunol Lett; 2017 Sep; 189():90-93. PubMed ID: 28577900
[TBL] [Abstract][Full Text] [Related]
27. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.
Jacobs J; Neeno T
Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.
Craig TJ; Bernstein JA; Farkas H; Bouillet L; Boccon-Gibod I
Int Arch Allergy Immunol; 2014; 165(2):119-27. PubMed ID: 25401373
[TBL] [Abstract][Full Text] [Related]
29. Shortened Activated Partial Thromboplastin Time May Help in Diagnosing Hereditary and Acquired Angioedema.
Bork K; Witzke G
Int Arch Allergy Immunol; 2016; 170(2):101-7. PubMed ID: 27463190
[TBL] [Abstract][Full Text] [Related]
30. Angioedema Due to Acquired Deficiency of C1-Inhibitor: A Cohort Study in Spain and a Comparison With Other Series.
Baeza ML; González-Quevedo T; Caballero T; Guilarte M; Lleonart R; Varela S; Castro M; Díaz C; Escudero E; García MG; Laffond E; Muñoz-Bellido FJ; Núñez R; Prior N; Sala-Cunill A; Sáenz de San Pedro B; Prieto-García A
J Allergy Clin Immunol Pract; 2022 Apr; 10(4):1020-1028. PubMed ID: 34844023
[TBL] [Abstract][Full Text] [Related]
31. Where we are with acquired angioedema due to C1 inhibitor deficiency: A systematic literature review.
Shi Y; Wang C
Clin Immunol; 2021 Sep; 230():108819. PubMed ID: 34358691
[TBL] [Abstract][Full Text] [Related]
32. Angioedema Without Wheals: Challenges in Laboratorial Diagnosis.
Grumach AS; Veronez CL; Csuka D; Farkas H
Front Immunol; 2021; 12():785736. PubMed ID: 34956216
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiency.
Castelli R; Wu MA; Arquati M; Zanichelli A; Suffritti C; Rossi D; Cicardi M
Br J Haematol; 2016 Mar; 172(6):902-8. PubMed ID: 26728240
[TBL] [Abstract][Full Text] [Related]
34. Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency.
Cugno M; Zanichelli A; Bellatorre AG; Griffini S; Cicardi M
Allergy; 2009 Feb; 64(2):254-7. PubMed ID: 19076541
[TBL] [Abstract][Full Text] [Related]
35. Nailfold Videocapillaroscopy Findings in Bradykinin-Mediated Angioedema.
Cesoni Marcelli A; Loffredo S; Petraroli A; Carucci L; Mormile I; Ferrara AL; Spadaro G; Genovese A; Bova M
J Investig Allergol Clin Immunol; 2021 Oct; 31(5):404-416. PubMed ID: 32301440
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency.
Bork K; Bernstein JA; Machnig T; Craig TJ
J Emerg Med; 2016 Apr; 50(4):567-80.e1. PubMed ID: 26826769
[TBL] [Abstract][Full Text] [Related]
37. "Nuts and Bolts" of Laboratory Evaluation of Angioedema.
Farkas H; Veszeli N; Kajdácsi E; Cervenak L; Varga L
Clin Rev Allergy Immunol; 2016 Oct; 51(2):140-51. PubMed ID: 27142368
[TBL] [Abstract][Full Text] [Related]
38. High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency.
Suffritti C; Zanichelli A; Maggioni L; Bonanni E; Cugno M; Cicardi M
Clin Exp Allergy; 2014 Dec; 44(12):1503-14. PubMed ID: 24552232
[TBL] [Abstract][Full Text] [Related]
39. Recognition and Differential Diagnosis of Hereditary Angioedema in the Emergency Department.
Pines JM; Poarch K; Hughes S
J Emerg Med; 2021 Jan; 60(1):35-43. PubMed ID: 33218838
[TBL] [Abstract][Full Text] [Related]
40. Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedema.
Riedl MA; Lumry WR; Li HH; Banerji A; Bernstein JA; Ba M; Bjrkander J; Magerl M; Maurer M; Rockich K; Chen H; Schranz J
Allergy Asthma Proc; 2016 Nov; 37(6):489-500. PubMed ID: 27931305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
